The Role of Vaginal Mesh Procedures in Pelvic Organ Prolapse Surgery in View of Complication Risk
Synthetic transvaginal mesh has been employed in the treatment of pelvic organ prolapse for more than a decade. As the use of these devices increased during this period so did adverse event reporting. In 2008, the Food and Drug Administration (FDA) Public Health Notification informed physicians and...
Saved in:
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2013-01-01
|
| Series: | Obstetrics and Gynecology International |
| Online Access: | http://dx.doi.org/10.1155/2013/356960 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1850179124203618304 |
|---|---|
| author | David R. Ellington Holly E. Richter |
| author_facet | David R. Ellington Holly E. Richter |
| author_sort | David R. Ellington |
| collection | DOAJ |
| description | Synthetic transvaginal mesh has been employed in the treatment of pelvic organ prolapse for more than a decade. As the use of these devices increased during this period so did adverse event reporting. In 2008, the Food and Drug Administration (FDA) Public Health Notification informed physicians and patients of rising concerns with the use of synthetic transvaginal mesh. Shortly thereafter and in parallel to marked increases in adverse event reporting within the Manufacturer and User Device Experience (MAUDE), the FDA released a Safety Communication regarding urogynecologic surgical mesh use. Following this report and in the wake of increased medical industry product withdrawal, growing medicolegal concerns, patient safety, and clinical practice controversy, many gynecologists and pelvic reconstructive surgeons are left with limited long-term data, clinical guidance, and growing uncertainty regarding the role of synthetic transvaginal mesh use in pelvic organ prolapse. This paper reviews the reported complications of synthetic transvaginal mesh with an evidence-based approach as well as providing suggested guidance for the future role of its use amidst the controversy. |
| format | Article |
| id | doaj-art-be8872f5c8b94d4980e1d6eeb42eefa4 |
| institution | OA Journals |
| issn | 1687-9589 1687-9597 |
| language | English |
| publishDate | 2013-01-01 |
| publisher | Wiley |
| record_format | Article |
| series | Obstetrics and Gynecology International |
| spelling | doaj-art-be8872f5c8b94d4980e1d6eeb42eefa42025-08-20T02:18:35ZengWileyObstetrics and Gynecology International1687-95891687-95972013-01-01201310.1155/2013/356960356960The Role of Vaginal Mesh Procedures in Pelvic Organ Prolapse Surgery in View of Complication RiskDavid R. Ellington0Holly E. Richter1Division of Urogynecology and Pelvic Reconstructive Surgery, Department of Obstetrics and Gynecology, University of Alabama at Birmingham, Birmingham, AL 35233, USADivision of Urogynecology and Pelvic Reconstructive Surgery, Department of Obstetrics and Gynecology, University of Alabama at Birmingham, Birmingham, AL 35233, USASynthetic transvaginal mesh has been employed in the treatment of pelvic organ prolapse for more than a decade. As the use of these devices increased during this period so did adverse event reporting. In 2008, the Food and Drug Administration (FDA) Public Health Notification informed physicians and patients of rising concerns with the use of synthetic transvaginal mesh. Shortly thereafter and in parallel to marked increases in adverse event reporting within the Manufacturer and User Device Experience (MAUDE), the FDA released a Safety Communication regarding urogynecologic surgical mesh use. Following this report and in the wake of increased medical industry product withdrawal, growing medicolegal concerns, patient safety, and clinical practice controversy, many gynecologists and pelvic reconstructive surgeons are left with limited long-term data, clinical guidance, and growing uncertainty regarding the role of synthetic transvaginal mesh use in pelvic organ prolapse. This paper reviews the reported complications of synthetic transvaginal mesh with an evidence-based approach as well as providing suggested guidance for the future role of its use amidst the controversy.http://dx.doi.org/10.1155/2013/356960 |
| spellingShingle | David R. Ellington Holly E. Richter The Role of Vaginal Mesh Procedures in Pelvic Organ Prolapse Surgery in View of Complication Risk Obstetrics and Gynecology International |
| title | The Role of Vaginal Mesh Procedures in Pelvic Organ Prolapse Surgery in View of Complication Risk |
| title_full | The Role of Vaginal Mesh Procedures in Pelvic Organ Prolapse Surgery in View of Complication Risk |
| title_fullStr | The Role of Vaginal Mesh Procedures in Pelvic Organ Prolapse Surgery in View of Complication Risk |
| title_full_unstemmed | The Role of Vaginal Mesh Procedures in Pelvic Organ Prolapse Surgery in View of Complication Risk |
| title_short | The Role of Vaginal Mesh Procedures in Pelvic Organ Prolapse Surgery in View of Complication Risk |
| title_sort | role of vaginal mesh procedures in pelvic organ prolapse surgery in view of complication risk |
| url | http://dx.doi.org/10.1155/2013/356960 |
| work_keys_str_mv | AT davidrellington theroleofvaginalmeshproceduresinpelvicorganprolapsesurgeryinviewofcomplicationrisk AT hollyerichter theroleofvaginalmeshproceduresinpelvicorganprolapsesurgeryinviewofcomplicationrisk AT davidrellington roleofvaginalmeshproceduresinpelvicorganprolapsesurgeryinviewofcomplicationrisk AT hollyerichter roleofvaginalmeshproceduresinpelvicorganprolapsesurgeryinviewofcomplicationrisk |